the aid library

Filter

345

Step-by-Step Approach for Development and Implementation of Hospital Antibiotic Policy and Standard Treatment Guidelines
recommended

World Health Organization (2011) C_WHO

Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h ... more

Medicines Patents, Access and Innovation

Brot für die Welt (2016) C2

The growing challenges for people in low and middle-income countries to access new medicines. Analysis 58

Guidelines for treatment of tuberculosis

World Health Organization (2010) C_WHO

4th edition. This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition

Not just in Transit: Drugs, the State and Society in West Africa

WACD West Africa Comission on Drugs WACD (2014) C1

An Independent Report of the West Africa Commission on Drugs

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc ... e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Geographical distribution of areas with a high prevalence of HTLV-1 infection

European Centre for Disease Prevention and Control (ECDC) (2015) C1

ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i ... more

Sierra Leone Health Promotion Strategy (2017-2021)

Government of Sierra Leone, Ministry of Health and Sanitation, Health Education Division (2016) C1

Tuberculosis in the Americas - Regional Report 2015

World Health Organization; Pan American Health Organization (2015) C_WHO

Epidemiology, Control, and Financing

Health in the green economy: Health Care Facilities

World Health Organization WHO (2021) C_WHO

WHO's Health in the Green Economy sector briefings examine the health impacts of climate change mitigation strategies considered by the Intergovernmental Panel on Climate Change in their Fourth Assessment Report.

Κατευθυντήριες oδηγίες του Παγκόσμιου Οργανισμού Υγείας για τη φαρμακευτική αντιμετώπιση του επίμονου πόνου σε παιδιά με διάφορες παθήσεις

World Health Organization (2013)

WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses

Ebola: Beyond the health emergency

Plan (2015)

Summary of research into the consequences of the Ebola outbreak for children and communities in Liberia and Sierra Leone This study describes the range of impacts that Ebola has had on children and families in Liberia and Sierra Leone, looking beyond the immediate health effects

Recommendations for investigating contacts of persons with infectious Tuberculosis in low- and middle-income countries

World Health Organization (2012) C_WHO

WHO/HTM/TB/2012.9

Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine

O. Morozova, S. Dvoryak a , ∗ , Frederick L. Altice (2013) C2

International Journal of Drug Policy 24 (2013) e91-98

Sector Development Strategy for Pharmaceutical Manufacturing in Zimbabwe 2017-2022

UN Industrial Development Organization (2019) CC

Project monitoring and evaluation (M&E) guide

International Federation of Red Cross And Red Crescent Societies (2011) C1

The guide is divided into 3 sections —the first focuses on the conceptual framework for M&E; the second focuses on six key steps for M&E; and further, the appendix provides additional tools, resources, and projects for M&E. With a comprehensive breakdown of the important approaches as well as a ch ... more

The concept of vulnerability in European asylum procedures

Minos Mouzourakis, Kris Pollet, Ruben Fierens European Council on Refugees and Exiles (ECRE), Asylum Information Database (AIDA) (2017) C2

Once identified as vulnerable, applicants enjoy specific rights and safeguards in the asylum process under EU law. Vulnerability should therefore trigger additional or tailored support to ensure that people have the necessary conditions to bring forward a claim for protection.

Kenya Registered Palliative Care Nursing: Curriculum

Kenya Medical Training College (KMTC) (2013) C1

Second-Line Antituberculosis Drugs in Children: A Commissioned Review for the World Health Organization 19th Expert Committee on the Selection and Use of Essential Medicines

Malgosia Grzemska, Elizabeth Mathai World Health Organization WHO (2013)

Achieving Health Equity in Contested Areas of Southeast Myanmar

Davis, Bill; Jolliffe, Kim The Asia Foundation (2016) C1

In many of Myanmar’s contested regions, healthcare services are provided through two parallel governance systems – by the government’s Ministry of Health, and by providers linked to ethnic armed organizations. Building upon efforts to build trust between these two actors following ceasefires s ... more